IMMUNOPHENOTYPING OF BIOLOGICAL MATERIAL TO IDENTIFY HEMOBLASTOSIS MARKERS IN BLAST CRISIS FOR SELECTING ADEQUATE POLYCHEMOTHERAPY IN HEMOBLASTOSIS. ijai 2024, 4 (07), 363-367.